Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) CEO Vininder Singh sold 14,405 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $2.65, for a total transaction of $38,173.25. Following the transaction, the chief executive officer now directly owns 2,478,041 shares in the company, valued at $6,566,808.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Vininder Singh also recently made the following trade(s):
- On Thursday, October 3rd, Vininder Singh sold 5,592 shares of Bullfrog AI stock. The stock was sold at an average price of $2.66, for a total value of $14,874.72.
- On Monday, July 8th, Vininder Singh sold 10,670 shares of Bullfrog AI stock. The shares were sold at an average price of $1.47, for a total value of $15,684.90.
- On Friday, July 5th, Vininder Singh sold 7,095 shares of Bullfrog AI stock. The stock was sold at an average price of $1.58, for a total value of $11,210.10.
Bullfrog AI Stock Down 3.2 %
BFRG stock opened at $2.70 on Friday. Bullfrog AI Holdings, Inc. has a 52 week low of $1.43 and a 52 week high of $8.35. The business has a 50-day simple moving average of $2.62 and a 200 day simple moving average of $2.71. The company has a market cap of $21.20 million, a PE ratio of -3.07 and a beta of -0.20.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in BFRG. Fortem Financial Group LLC acquired a new stake in shares of Bullfrog AI in the 1st quarter valued at $171,000. Renaissance Technologies LLC bought a new stake in shares of Bullfrog AI during the 2nd quarter worth $34,000. Finally, XTX Topco Ltd acquired a new stake in Bullfrog AI in the second quarter valued at about $32,000. 0.96% of the stock is currently owned by institutional investors and hedge funds.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Further Reading
- Five stocks we like better than Bullfrog AI
- How to invest in marijuana stocks in 7 stepsĀ
- Beat the Volatility: Top 3 Low-Beta Stocks to Watch
- What is Insider Trading? What You Can Learn from Insider Trading
- Visa and Mastercard: Top Payment Stocks to Watch After Rate Cuts
- How to Use the MarketBeat Excel Dividend Calculator
- When Is the Best Time to Invest in Mutual Funds?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.